Mumbai, May 14 -- Wockhardt Hospitals Pvt. Ltd, part of the Habil Khorakiwala-promoted Wockhardt Group, has chalked out an expansion plan, nearly six years after it sold off a major portion of its business to Fortis Healthcare Ltd. In 2009, the ... HT Syndication, 1 week ago
'Drug recall is to speed up the regulatory compliance process' - Money Today, 2 weeks ago
We should be able to recover 50-60% sales from Chikalthana: Habil Khorakiwala, Wockhardt - Financial Express, 2 months ago
1 images for "habil khorakiwala"
News Top News Top Story India Infoline News Service | Mumbai | May 22, 2015 16:43 IST This is the third product from Wockhardt to receive this coveted status after WCK 771 and WCK 2349 last year and provides a strong boost to its drug ...India Infoline, 4 hours ago Wockhardt 's new antibiotic drug WCK 4873 gets QIDP status from US FDA PharmaBiz, 6 hours ago Wockhardt gets special status in US on antibiotics Hindu Business Line, 22 hours ago Wockhardt gets QIDP status for pneumonia drug from USFDA Economic Times, 1 day ago
More from: DNA, DNA...and 2 other sources
Wockhardt shares gained nearly 4 per cent to Rs 1459.50 on Friday, after the company received a QIDP or qualified infectious disease product status from the US Food and Drug Administration (FDA) for one of its products. Wockhardt shares at 11:28 ...NDTV Profit, 10 hours ago Wockhardt shares up 2% on FDA grants QIDP status to new drug Business Today India, 10 hours ago
Wockhardt has decided to voluntarily recall all the remaining batches of 12-15 products that were manufactured in the Chikalthana and Waluj facilities prior to the import alert imposed by the US Food and Drug Administration (US FDA) recently.Financial Express, 1 day ago Wockhardt faces long haul on FDA travails, Business Today says FierceMedicalDevices, 2 days ago Now, 93,393 bottles of blood pressure drug recalled by Wockhardt DNA India, 1 week ago Troubled Wockhardt recalls blood pressure med in U.S. FiercePharmaManufacturing, 1 week ago
Browse more on » Other , Awards Mukesh Ambani ranked first in Forbes list of 100 richest Indian tycoons. This is the eighth time in a row that the Chairman of Reliance Industries has topped the list. Tweet Mumbai, Maharashtra, April 29, 2015 / ...IndiaPRwire, 1 week ago
Indian billionaires have lost a whopping $4.6 billion in Wednesday’s market crash with pharma king Dilip Shanghvi, banker Uday Kotak and infra and commodities czar Gautam Adani bearing the maximum brunt in terms of loss of notional wealth. Among the over 80 ...The Financial Chronicle, 2 weeks ago
5:00pm: The Indian rupee closes 0.55% stronger against the dollar at 63.15, marking its sharpest gain since 9 January. Read more 3:30pm: The S&P BSE Sensex closes 0.81%, or 219.39 points, higher at 27,396.38, while the Nifty added 0.87%, or 71.80 ...Livemint.com, 3 weeks ago
India April 28(IM):The S&P BSE Sensex surges 1.11%, or 301.82 points, to 27,478.81, while the CNX Nifty rises 1.10%, or 90.20 points, to 8,304. 2:58pm: The S&P BSE Sensex surges 1.04%, or 283.69 points, to 27,460.68, while the CNX Nifty rises 0.95%, ...Indian Mirror, 3 weeks ago
Indian pharmaceutical companies have reaped significant gains from sale of cheaper generic versions of blockbuster drugs in the US market. Now, the next frontier is the complex generics market to ride the next wave of growth. This high potential ...Financial Express, 1 month ago
No major findings from recent USFDA inspection, after 2013 import alert on the company's Aurangabad-based Waluj and Chikalthana facilities Wockhardt Pharma's Chikalthana facility in Maharashtra recently underwent a 10-day-long inspection by the ...Financial Express, 1 month ago Wockhardt's Chikalthana plant to regain the lost ground soon Financial Express, 2 months ago
on your WebpageAdd Widget >Get your members hooked!